Record FY21 results delivers sustainable growth
Filed with ASX · · 5 pages · English
• Beamtree reports strongest revenue performance to date with 109% growth to $8.9mil for financial year ending 30 June 2021 o Group revenue grew 20% on a pro forma basis o New contracts and organic growth resulted in 15% increase in annualised recurring revenue (ARR) to $6.7m pro forma o Recurrent revenues were at 78% of operating revenues o Strong cash position of $14.1mil and zero debt o Operati
In the deck
Earlier from Beamtree
- Successful renewal of key contracts and new contract wins
- Appendix 4D and Interim Report
- PKS receives $12 million in firm commitments to drive growth
- PKS executes $2.5m renewal agreement with Philips
- PKS agreement with ACT Pathology extended
Later from Beamtree
- Investor Presentation Financial Year 2021
- Beamtree to acquire Potential(x)
- Proposed issue of securities - BMT
- Beamtree acquisition presentation
- BMT and CALHN partner to pioneer AI for safer patient care
Follow Beamtree into a list and get an email when it puts out news.
Follow Beamtree